The role of metabolites and metabolomics in clinically applicable biomarkers of disease.
about
Blood transcriptomics and metabolomics for personalized medicineOmics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric DisordersBiomarkers of Nutrition for Development-Folate ReviewApplication of metabolomics in drug resistant breast cancer researchMetabolomics and its potential in diagnosis, prognosis and treatment of rheumatic diseasesApplying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the futureAdvanced molecular biologic techniques in toxicologic diseaseUntargeted plasma metabolite profiling reveals the broad systemic consequences of xanthine oxidoreductase inactivation in miceText-mining-assisted biocuration workflows in ArgoFeature Selection Methods for Early Predictive Biomarker Discovery Using Untargeted Metabolomic Data.Random Survival Forest in practice: a method for modelling complex metabolomics data in time to event analysis.Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis.GC-TOFMS analysis of metabolites in adherent MDCK cells and a novel strategy for identifying intracellular metabolic markers for use as cell amount indicators in data normalization.Plasma free amino acid profiling of esophageal cancer using high-performance liquid chromatography spectroscopy.Bioinformatics Tools for Mass Spectroscopy-Based Metabolomic Data Processing and Analysis.Serum amino acid profiles and their alterations in colorectal cancer.Relative quantification of amine-containing metabolites using isobaric N,N-dimethyl leucine (DiLeu) reagents via LC-ESI-MS/MS and CE-ESI-MS/MS.Overview of mass spectrometry-based metabolomics: opportunities and challenges.Analytical methods in untargeted metabolomics: state of the art in 2015.Bioinformatics tools for cancer metabolomics.Application of metabolomics to prostate cancer.Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profilingMetabolomic fingerprint of heart failure with preserved ejection fraction.The utility of metabolomics in natural product and biomarker characterization.Metabolic changes in rat urine after acute paraquat poisoning and discriminated by support vector machine.iMet-Q: A User-Friendly Tool for Label-Free Metabolomics Quantitation Using Dynamic Peak-Width Determination.Beneficial Regulation of Metabolic Profiles by Black Raspberries in Human Colorectal Cancer Patients.Metabolic Profiling of Total Physical Activity and Sedentary Behavior in Community-Dwelling Men.Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple SclerosisSerum Metabolite Profiles Are Altered by Erlotinib Treatment and the Integrin α1-Null Genotype but Not by Post-Traumatic OsteoarthritisIdentifying metabolite markers for preterm birth in cervicovaginal fluid by magnetic resonance spectroscopyMetabolomic markers for intestinal ischemia in a mouse model.Biomarker Discovery and Translation in Metabolomics.Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue.Key messages of recent publications in the field of toxicology.In-Depth Characterization and Validation of Human Urine Metabolomes Reveal Novel Metabolic Signatures of Lower Urinary Tract Symptoms.Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics.Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging.A review of applications of metabolomics in cancer.
P2860
Q26772073-F7A681B3-7553-4772-842E-C77937DE08BAQ26784904-1632796C-35B8-4BF1-AEA1-2F9E198CC41DQ26785463-00410CC6-6E9D-4065-9957-95EFC2D9792BQ26866291-2D4A43ED-1C67-41E2-9338-925B7D1DCAD6Q27022390-ABF21F71-7E19-4622-9EE6-444BB848FC4DQ28074451-B471E5FB-B769-40CB-AC31-B292DA9F317BQ28393388-9F8D118E-409A-40F7-90A3-9F96B2CB12BFQ28480520-EB18324A-B13D-4BA2-8984-F0EB35303AD1Q28540893-AD6A6527-3445-4F2B-910B-445F061F39AEQ31117573-25A30D08-7F0D-492F-A476-41A98C431406Q31126519-08F95A33-BBAF-4168-B7D6-DAAD7774C166Q33699851-2D99BCCE-F706-4CE2-8942-3353AB11090DQ33887061-6D51D13F-5AB1-4DC1-93AB-4E1C387FC69FQ33887109-EE3A3397-8802-4B1A-BBD5-5C89A2DEB2D7Q34205992-1866E1EF-0244-400E-B979-7D59C071EF18Q34660782-C183224B-8143-47DB-AE8A-387938CFFAC2Q34859719-790EF545-8EC1-43CF-94DD-80422F47D22CQ35108784-F593EFCC-348F-4FD4-B639-A7C1758BCF02Q35149924-7D0A9AD1-FC13-4D65-A35E-ECB1E9F60D8BQ35163111-56A21855-CF3F-4B8D-9541-6A0D9F3F7E16Q35234286-EF490D21-E549-431D-8497-CC124B395527Q35501184-B47ABC1C-6E0F-40AD-8BBE-5DC1D05E45EFQ35641415-4289959B-12F9-4510-8EAB-824A4A92D04CQ35762668-0AC573DB-9A54-4005-B52E-4F5CFE49990CQ35792271-5B46998F-81B9-4B44-ABD4-E08EECDC5638Q35897656-B74BD042-D9BD-4CC2-AD15-B920E37D9898Q35925208-F72A8D52-4D30-4CD8-B202-66F97A42F7D0Q36163882-D2AD3A7A-1776-4758-8C81-517BB0F06FE7Q36407218-0AFC0116-A0BC-4BCA-B376-CEEB14D91333Q36654870-92ED5229-C3AF-4264-8CEB-28BEE5CD28EFQ36665677-33212138-4D7E-42E0-BA28-4AB5228045D4Q36839717-7CAA7F74-6302-4B33-A973-E790CFD0F3B7Q36845593-EE79C01F-750D-43BE-97AB-BCDE2DCC8B85Q36913528-AD39F38E-DC39-480B-8787-D71E5B0A71E1Q36937203-0B4907C8-443A-42A1-B873-27351E2F8973Q37035881-6562775D-24E0-456A-B3B5-B82CA0C94B6CQ37159996-4D37B0C0-62DF-4488-B1D7-82CECA7E6E13Q37334196-44487863-A7F2-4E8E-92FD-2A55535735E4Q37485378-452EEF15-9D1A-4ADE-9072-703E67CC7C99Q37512830-5CE9B62B-002A-4864-A421-EED257A4BFF4
P2860
The role of metabolites and metabolomics in clinically applicable biomarkers of disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of metabolites and metabolomics in clinically applicable biomarkers of disease.
@en
The role of metabolites and metabolomics in clinically applicable biomarkers of disease.
@nl
type
label
The role of metabolites and metabolomics in clinically applicable biomarkers of disease.
@en
The role of metabolites and metabolomics in clinically applicable biomarkers of disease.
@nl
prefLabel
The role of metabolites and metabolomics in clinically applicable biomarkers of disease.
@en
The role of metabolites and metabolomics in clinically applicable biomarkers of disease.
@nl
P2860
P50
P1476
The role of metabolites and metabolomics in clinically applicable biomarkers of disease
@en
P2093
Ludwig Neyses
P2860
P2888
P356
10.1007/S00204-010-0609-6
P577
2010-10-16T00:00:00Z